Clinical Trial

Evaluation of the Effect of Kefir Consumption

Study acronym: Kefirness
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Many societies traditionally use fermentation as a means of producing beverages, whose microbial transformation is spontaneously triggered or facilitated by the addition of a catalyst (yeasts, bacteria). Kefir is a traditional beverage belonging to the latter category. It is a probiotic that is supposed to modify the intestinal microbiota and the metabolites produced. Links between kefir and metabolic syndromes (insulin resistance, etc.) have also been described in animal models. Very few clinical studies have evaluated the effects of kefir in humans. A 'positive feeling' has also been described by people who consume kefir. Kefir could therefore have an effect on people's well-being.
Trial Details
NCT Number NCT07522372
Lead Sponsor Sys2Diag
Collaborators: Centre National de la Recherche Scientifique, France
Conditions Emotion, Well-being
Enrollment 66 participants
Start Date 2024-06-04
Primary Completion 2025-06-11 (estimated)
Study Completion 2027-06-11 (estimated)
Updated on ClinicalTrials.gov 2026-04-13